Antibiofilm approaches as a new paradigm for treating infections.
Antibiotic resistance is a pressing issue. ๐ฆ New antibiofilm strategies may offer hope for treating stubborn infections. ๐ก
November 9, 2024
Follow us
latest articles
Discover the newest research about AI innovations in ๐งช Drug Discovery.
Revolutionizing Healthcare with BiomedGPT: A New Era of AI Insights
BiomedGPT combines AI for biomedical images and text, enhancing healthcare insights and decision-making. ๐ค๐ฉบ
November 8, 2024
Revolutionary AI Tool Enhances Understanding of Protein Interactions in Disease Treatment
New AI tool PIONEER predicts protein interactions, aiding drug development for over 10,500 diseases. ๐งฌ๐
October 30, 2024
Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls.
AI enhances pharmaceutical safety by predicting product recalls. Key factors include formulation complexity and manufacturing processes. ๐๐
October 24, 2024
Unraveling Cordia myxa’s anti-malarial potential: integrative insights from network pharmacology, molecular modeling, and machine learning.
Cordia myxa shows promise against malaria. ๐ฟ Key compounds identified may target IL6 and CASP3. ๐ฆ Further studies needed.
October 21, 2024
FuseLinker: Leveraging LLM’s pre-trained text embeddings and domain knowledge to enhance GNN-based link prediction on biomedical knowledge graphs.
FuseLinker enhances link prediction in biomedical knowledge graphs using advanced embeddings and GNNs. Promising results for drug repurposing! ๐๐
October 19, 2024
Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation.
AlphaFold’s impact on molecular biology is significant. ๐ Emerging trends and research hotspots reveal vast exploration opportunities. ๐
October 7, 2024
Revolutionizing Cancer Treatment with AI-Driven Protein Analysis
AI-driven protein analysis transforms cancer treatment, enhancing diagnosis and drug design. Promising advancements in personalized healthcare. ๐งฌ๐ก
October 6, 2024
A foundation model for clinician-centered drug repurposing.
A new AI model, TxGNN, enhances drug repurposing accuracy for various diseases. Promising results for clinicians. ๐๐
September 26, 2024
PharmaBench: Enhancing ADMET benchmarks with large language models.
PharmaBench improves ADMET benchmarks using large language models, enhancing drug development accuracy. ๐งฌ๐ Comprehensive dataset aids AI model creation.
September 21, 2024